000			01275 a2200373 4500
005			20250514225033.0
264		0	_c20050630
008			200506s 0 0 eng d
022			_a1521-6616
024	7		_a10.1016/j.clim.2005.02.006 _2doi
040			_aNLM _beng _cNLM
100	1		_aSutton, Steven A
245	0	0	_aAnti-IL-5 and hypereosinophilic syndromes. _h[electronic resource]
260			_bClinical immunology (Orlando, Fla.) _cApr 2005
300			_a51-60 p. _bdigital
500			_aPublication Type: Journal Article; Review
650	0	4	_aAdult
650	0	4	_aAntibodies, Monoclonal _xtherapeutic use
650	0	4	_aBenzamides
650	0	4	_aFemale
650	0	4	_aHumans
650	0	4	_aHypereosinophilic Syndrome _xdiagnosis
650	0	4	_aImatinib Mesylate
650	0	4	_aInterleukin-5 _xantagonists & inhibitors
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aPiperazines _xtherapeutic use
650	0	4	_aProtein Kinase Inhibitors _xtherapeutic use
650	0	4	_aPyrimidines _xtherapeutic use
700	1		_aAssa'ad, Amal H
700	1		_aRothenberg, Marc E
773	0		_tClinical immunology (Orlando, Fla.) _gvol. 115 _gno. 1 _gp. 51-60
856	4	0	_uhttps://doi.org/10.1016/j.clim.2005.02.006 _zAvailable from publisher's website
999			_c15536114 _d15536114